Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Ng L, Poon RT, Pang R.

Cell Mol Life Sci. 2013 Oct;70(19):3631-56. doi: 10.1007/s00018-013-1266-8. Epub 2013 Jan 31. Review.

PMID:
23370778
2.

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR.

Cancer Microenviron. 2014 Dec;7(3):117-31. doi: 10.1007/s12307-014-0148-4. Epub 2014 Jun 18.

3.

The gastrointestinal tumor microenvironment.

Quante M, Varga J, Wang TC, Greten FR.

Gastroenterology. 2013 Jul;145(1):63-78. doi: 10.1053/j.gastro.2013.03.052. Epub 2013 Apr 10. Review.

4.

Cancer stem cells in human gastrointestinal cancer.

Taniguchi H, Moriya C, Igarashi H, Saitoh A, Yamamoto H, Adachi Y, Imai K.

Cancer Sci. 2016 Nov;107(11):1556-1562. doi: 10.1111/cas.13069. Review.

5.

Chemokine receptor CXCR4: role in gastrointestinal cancer.

Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E.

Crit Rev Oncol Hematol. 2013 Dec;88(3):696-705. doi: 10.1016/j.critrevonc.2013.08.005. Epub 2013 Aug 28. Review.

PMID:
24120239
6.

Breast cancer stem cells: Multiple capacities in tumor metastasis.

Geng SQ, Alexandrou AT, Li JJ.

Cancer Lett. 2014 Jul 10;349(1):1-7. doi: 10.1016/j.canlet.2014.03.036. Epub 2014 Apr 12. Review.

7.

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.

Galván JA, Astudillo A, Vallina A, Fonseca PJ, Gómez-Izquierdo L, García-Carbonero R, González MV.

Am J Clin Pathol. 2013 Jul;140(1):61-72. doi: 10.1309/AJCPIV40ISTBXRAX.

PMID:
23765535
9.

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Shukla HD, Mahmood J, Vujaskovic Z.

Cancer Lett. 2015 Dec 1;369(1):28-36. doi: 10.1016/j.canlet.2015.08.003. Epub 2015 Aug 11. Review.

PMID:
26276717
10.

Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer.

Iwatsuki M, Toyoshima K, Watanabe M, Hayashi N, Ishimoto T, Eto K, Iwagami S, Baba Y, Yoshida N, Hayashi A, Ohta Y, Baba H.

Br J Cancer. 2013 Nov 26;109(11):2829-32. doi: 10.1038/bjc.2013.680. Epub 2013 Nov 7.

11.

Emerging molecular basis of hematogenous metastasis in gastric cancer.

Zhong J, Chen Y, Wang LJ.

World J Gastroenterol. 2016 Feb 28;22(8):2434-40. doi: 10.3748/wjg.v22.i8.2434. Review.

12.

MicroRNAs associated with metastatic prostate cancer.

Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y.

PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30.

13.

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.

Mimeault M, Batra SK.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):234-54. doi: 10.1158/1055-9965.EPI-13-0785. Epub 2013 Nov 22. Review.

14.

Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.

Achyut BR, Yang L.

Gastroenterology. 2011 Oct;141(4):1167-78. doi: 10.1053/j.gastro.2011.07.048. Epub 2011 Aug 11. Review.

PMID:
21839702
15.

Diagnostic, Prognostic, and Predictive Molecular Biomarkers and the Utility of Molecular Imaging in Common Gastrointestinal Tumors.

Idowu MO, Laudadio J, Rizzo K.

Biomed Res Int. 2015;2015:890805. doi: 10.1155/2015/890805. Epub 2015 Nov 4. No abstract available.

16.

The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.

Wood SL, Pernemalm M, Crosbie PA, Whetton AD.

Cancer Treat Rev. 2014 May;40(4):558-66. doi: 10.1016/j.ctrv.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24176790
17.

Hypoxic control of metastasis.

Rankin EB, Giaccia AJ.

Science. 2016 Apr 8;352(6282):175-80. doi: 10.1126/science.aaf4405. Epub 2016 Apr 7. Review.

18.

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E.

Cancer Res. 2008 Apr 1;68(7):2329-39. doi: 10.1158/0008-5472.CAN-07-5167.

19.

Metastatic biomarker discovery through proteomics.

Brinton LT, Brentnall TA, Smith JA, Kelly KA.

Cancer Genomics Proteomics. 2012 Nov;9(6):345-55. Review.

PMID:
23162074
20.

Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.

Luo Y, Zhang X, Tan Z, Wu P, Xiang X, Dang Y, Chen G.

PLoS One. 2015 Dec 28;10(12):e0145659. doi: 10.1371/journal.pone.0145659. eCollection 2015.

Supplemental Content

Support Center